On the afternoon of June 6, Chairman Fu Yuning paid a research visit to CR Double Crane, hearing reports of Deputy General Manager Li Fuzuo and heads of CR Double Crane and talking with the management team of CR Double Crane in the company of Vice Chairman Wan Yin of the Group.

Fu spoke highly of the innovative achievements of CR Double Crane and the plan for future strategic development of the enterprise. He pointed that the GSK Event sounded alarm for the whole pharmaceutical industry. As a pharmaceutical enterprise, CR Double Crane should thoroughly consider the following questions: What business mode will sustain the long-term existence of the enterprise? How should the enterprise beak the bottleneck of the infusion business and make it a new point of business growth? Does the existing organizational capacity of the company meet needs of the transformation of the business mode? Fu stressed that a pharmaceutical company can win the market only with competitive products. Integrity is important for a company as it is for an individual. To make a good company, we should first develop ourselves as individuals of virtue and should never do anything that undermines the image and development of the company.

During the visit, Fu also visited the Exhibition of the Development Achievements of CR Double Crane and had a in-depth knowledge of the development CR Double Crane.